Inarticulate ramblings of a management consultant

the day to day experiences of a consultant operating in weird and wonderful client situations

Value Preservation

Asian Investors -hierarchical?

The second in my series of capital flows from East to West….and the consequences for European / UK and American leaders. You will find the first here…I would recommend that you read them in the order that they are written! One of the biggest challenges for Western CEOs facing the prospect of Asian ownership is understanding the formal and informal nature of governance. There is a perception amongst many, based […]

Continue Reading →

The market needs certainty…really?

On the morning after the most extraordinary day in British political history, the clamour in every publicly traded market is for certainty… about the timing of the triggering of Article 50, about the new leadership of the Conservative Party (and the Labour Party), about the terms of the agreement with the EU, about the position of the rest of the UK (in particular Scotland and Northern Ireland) etc! As an […]

Continue Reading →

Show me the value…!

Think about a recent acquisition that you were involved in. Having accessed the business in the post completion period, which of the following assets proved to be more valuable: The physical assets: Intellectual property, technology platform, operating infrastructure, plant and equipment, inventory / working capital, cash in the bank. The employee assets: innovators, R&D experts, operations managers, leaders, customer facing relationship managers, sales people, ‘historians’ (those who understood the context […]

Continue Reading →

The love affair between Fintech and financial services – unrequited?

Large consulting firms buying / investing in small specialists Telecommunications giants buying / investing in tiny adtech ventures Banks and insurance companies buying / investing in owner managed fintech businesses Once again we are on the crest of a wave of mergers and acquisitions whereby the very large swallow the very small. I’m not at all confident that we won’t have the same result the last time this happened…in the […]

Continue Reading →

Revenue synergies – the last great hope in the justification of paying too much for too little

The announcement this morning of the acquisition of Baxalta by Shire suggests that the wave of pharmaceutical acquisitions is still ongoing. The current market fluctuation may help others to continue their quest in what is probably the largest sector consolidation we’ve seen in a decade or two. The Shire share price reaction is also interesting…a fall of 8% suggests that investors are increasingly concerned that for this specific deal, and […]

Continue Reading →

Fixing the irrevocably broken – creating an organisational structure which can thrive in a world of disruptive innovation

With thanks to Toby Tester and following from my blog last week (click here to read it if you’ve unwittingly stumbled upon this random collection of thoughts), here is the exam question for the week: What does an ideal organisational structure look like to cope with the challenges of today’s working environment? Let me first try and define what I envisage as an ‘ideal’ structure with a series of questions: […]

Continue Reading →

Acquisition in an emerging market – integrating the ‘ways of working’ – an exercise in futility?

The final instalment of this series of blogs, from the perspective of a mythical CEO of a family owned business being acquired by a multinational corporate. It is based on my experience of deals across Asia and is not specific to one particular transaction. If you’d like to read the previous parts (which may make sense as they’re written in chronological order), you can access them here – Due diligence, […]

Continue Reading →